[Update on hepatorenal syndrome]

Nephrologie. 2002;23(1):11-7.
[Article in French]

Abstract

The hepatorenal syndrome is a form of renal failure occurring in patients with advanced liver disease. The diagnosis is based both on the demonstration of low GFR and exclusion of other common causes of renal failure that may occur in patients with cirrhosis. Orthotopic liver transplantation remains the only curative treatment for this poor outcome disease; other modalities such as vasopressin analogues, transjugular intrahepatic portosystemic shunt or renal replacement therapies may serve as a bridge to transplantation. This article reviews the pathophysiology, diagnosis and current treatment of hepatorenal syndrome.

Publication types

  • Review

MeSH terms

  • Acute Kidney Injury / chemically induced
  • Acute Kidney Injury / diagnosis
  • Creatinine / blood
  • Diagnosis, Differential
  • Edema / etiology
  • Glomerular Filtration Rate
  • Hepatorenal Syndrome* / diagnosis
  • Hepatorenal Syndrome* / drug therapy
  • Hepatorenal Syndrome* / etiology
  • Hepatorenal Syndrome* / physiopathology
  • Hepatorenal Syndrome* / surgery
  • Humans
  • Liver Cirrhosis / complications
  • Liver Cirrhosis / physiopathology
  • Liver Transplantation
  • Peritoneovenous Shunt
  • Portasystemic Shunt, Surgical
  • Renal Circulation / drug effects
  • Renal Replacement Therapy
  • Renin-Angiotensin System / physiology
  • Serum Albumin / deficiency
  • Splanchnic Circulation / drug effects
  • Vasoconstrictor Agents / pharmacology
  • Vasoconstrictor Agents / therapeutic use
  • Vasodilator Agents / pharmacology
  • Vasodilator Agents / therapeutic use
  • Vasopressins / metabolism
  • Water-Electrolyte Imbalance / etiology

Substances

  • Serum Albumin
  • Vasoconstrictor Agents
  • Vasodilator Agents
  • Vasopressins
  • Creatinine